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ABSTRACT
Objectives The aim of this study was to adapt and 
validate the Pain Assessment in Advanced Dementia 
(PAINAD) scale in Spanish.
Design Cross- sectional observational study.
Setting Two health districts of Andalusian provinces, 
located in the south of Spain, through the Andalusian 
network of Primary Healthcare centres and four institutions 
dedicated to the care of patients with dementia.
Participants A total of 100 older people, with a medical 
diagnosis of dementia and a score on the Global 
Deterioration Scale between 5 and 7 were assessed using 
the PAINAD scale.
Primary and secondary outcome 
measures Psychometric properties including content 
validity, construct validity and reliability of the scale have 
been tested.
Results The overall Item Content Validity Index was 
excellent (0.95). Regarding construct validity, it was 
confirmed that a lower use of analgesics implied a 
lower score on the PAINAD scale (p<0.05). The internal 
consistency of the scale was 0.76 and it increases to 
0.81 if we remove the breathing item. Furthermore, the 
intraclass correlation coefficient (ICC) used to assess 
interobserver reliability was 0.94, whereas the ICC used to 
assess temporary stability was 0.55.
Conclusions The Spanish version of the PAINAD scale is 
a valid tool to assess pain in patients with dementia and 
inability to communicate verbally.
INTRODUCTION
Pain is an unresolved problem in older 
people, especially in those with cognitive 
impairment.1 It is estimated that 50% of older 
people and 80%–85% of older people with 
dementia suffer pain as a result of suffering 
various chronic conditions.2–4 In addition, 
the prescription of analgesics is significantly 
lower in older people with dementia than 
among those with preserved cognitive abili-
ties.5 6 This difference could be explained by 
the fact that pain assessment in people with 
advanced dementia is clearly hampered by 
both loss of verbal communication ability and 
impaired perception and identification of 
painful experiences.2 7
In this sense, self- reports of the person on 
pain are considered the gold standard due to 
their reliability discerning the presence and 
severity of pain. However, the usefulness of 
these self- reports is stage- dependent, partic-
ularly limited by impaired verbal communi-
cation in people with advanced dementia.8 9 
Therefore, in people with this condition and 
inability to communicate effectively verbally, 
behavioural observation- based pain assess-
ment tools become the best choice for 
assessing pain.10–12
This alternative to verbal assessment of 
pain in people with advanced dementia has 
promoted the development of more than 24 
Strengths and limitations of this study
 ► Despite the previous existence of a Spanish ver-
sion of the Pain Assessment in Advanced Dementia 
(PAINAD) scale, the validation and cultural adaptation 
process began with a translation/retro- translation of 
the original scale, guaranteeing the content of the 
scale.
 ► The PAINAD scale was completed by three research-
ers previously trained in its use to assess pain.
 ► Special attention was paid to the homogeneity of 
external conditions during the pain assessment pro-
cess using the PAINAD scale.
 ► The study subjects were selected by consecutive 
sampling as there was no prior list of subjects meet-
ing the inclusion criteria for the study, and this could 
interfere with the selection of participants.
 ► The time between test–retest, which happened 
30 days apart, may have influenced the results 
achieved.
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tools with this same objective, which have been adapted 
and validated in other languages.5 13–17 Specifically, the 
most recommended tools for pain assessment in this 
population are the Abbey Pain scale,18 Doloplus 2,19 the 
Assessment of Pain in Elders with Dementia scale,20 the 
Non- communicative Patient’s Pain Assessment Instru-
ment,21 the Checklist of Non- verbal Pain Indicators,22 the 
Pain Assessment Checklist for Seniors with Limited Ability 
to Communicate (PACSLAC)23 and the Pain Assessment 
in Advanced Dementia (PAINAD) scale.24
However, previous studies point to the PACSLAC scale 
as the tool of choice for research studies, and the PAINAD 
scale as the ideal tool for assessing pain in clinical prac-
tice.25–28 Therefore, the PAINAD scale has been culturally 
adapted and validated for the assessment of pain in people 
with advanced dementia in different countries, such as 
Singapore,29 the Netherlands,30 Italy,31 China,32 the UK,33 
the USA,34 Brazil,35 Turkey36 and Germany.37 However, its 
previous validation in Spanish has been superficial due 
to limitations of sample size and sample origin,38 39 and 
further validation studies with larger samples are there-
fore required.40
Objective
The main objective of this study is to adapt and vali-
date the PAINAD scale in the Spanish language. The 
specific objectives will also be to evaluate the content 
and construct validity and the internal consistency of the 
Spanish version of the scale.
METHODS
Design
Cross- sectional observational study conducted in two 
health districts of Andalusian provinces, located in the 
south of Spain, through the Andalusian network of 
Primary Healthcare centres and four institutions dedi-
cated to the care of patients with dementia. This study 
began in May 2018 and finished in May 2020.
Participants and selection criteria
The study participants were patients with dementia or 
Alzheimer’s disease (AD) meeting the following inclusion 
criteria:
 ► Age ≥65 years.
 ► Being diagnosed with dementia or AD with a Global 
Deterioration Scale (GDS) score between 5 and 7.41 
Patients received diagnosis of dementia if they met 
Diagnostic and Statistical Manual of Mental Disor-
ders—V clinical criteria and received a diagnosis of 
probable or possible AD according to the National 
Institute of Neurological and Communicative Disor-
ders and Stroke/Alzheimer’s Disease and Related 
Disorders Association criteria.
 ► Being unable to communicate verbally.
 ► Having received healthcare at the community level for 
at least 3 months because of a diagnosis of dementia. 
In the case of the institution dedicated to the care of 
patients with dementia, the patients included were 
those who had been using this service for at least 
3 months.
 ► Having a relative or legal representative that could 
sign the informed consent for the participation of the 
patient in the study.
The recruitment of the patients with dementia was 
conducted consecutively by the interventional nurses 
among the subjects under their care in their healthcare 
institution. In this sense, all patients meeting the inclu-
sion criteria were included in the study.
Regarding the sample size, between 5 and 20 subjects 
per item are needed to validate scales, or, at least, 100 
subjects in scales with less than 10 items. Therefore, the 
number of subjects needed for validation of the PAINAD 
scale is 100 subjects.42
Measures
For the description of the sample, the following sociode-
mographic and clinical variables were collected: sex, age, 
marital status, medical diagnosis of dementia, GDS score, 
Barthel Index score and use of analgesics.
Likewise, pain in people with advanced dementia and 
impaired verbal communication was evaluated at rest 
using the PAINAD scale by three researchers previously 
trained in its use and specific interpretation of each item. 
This scale is composed of five items: breathing, nega-
tive vocalisation, facial expression, body language and 
consolability. Each of these dimensions was evaluated by 
the observer using a Likert- type scale (0–2) based on the 
pain severity. The total score will result from the sum of 
the values obtained in the five items, ranging between 0 
and 10 points.
In general, clinical and sociodemographic vari-
ables were collected from the patient’s medical history. 
However, the scales (GDS and Barthel Index) were admin-
istered by the research team at the time of data collection 
or, if collected from the medical record, were not more 
than 3 months old.
Adaptation and validation of the PAINAD scale
Linguistic adaptation and validation
The linguistic validation process was performed using the 
forward–backward translation method. However, the exis-
tence of the Spanish version published by García- Soler et 
al38 allowed us to start from this version to skip the trans-
lation of the tool from English to Spanish. Therefore, 
two translators, whose native language was English, with 
experience in health sciences, and specifically in nursing, 
were identified to translate the García- Soler et al version 
independently38 into English. The two versions of the 
scale resulting from this process were unified to obtain a 
single back- translation that was compared with the orig-
inal24 to check the level of discrepancy. If 5% or more of 
discrepancy in the use of words with the same meaning 
was found, the linguistic validation process would be 
restarted.
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Content validity
The translated version of the tool was submitted to eight 
independent experts with the following selection criteria: 
bilingual nurses or other health professionals, with clin-
ical experience in caring for people with AD and other 
dementias, familiar with the research process and with 
regular access to email. However, two additional backup 
experts were identified to replace possible losses.
Once the experts were identified, they were formally 
invited to participate in the project via an email, which 
contained a letter requesting their participation and a 
document containing the two versions of the PAINAD 
scale (the original in English and the Spanish version).
The participation of each expert consisted in the deter-
mination of whether each item on the scale was relevant 
to the study population and whether the wording was 
appropriate. For this purpose, they rated the items with 
an ordinal scale from 1 (irrelevant) to 4 (highly relevant). 
Each expert was allowed 10 days to complete the evalua-
tion form.
Construct validity
The hypothesis to assess the validity of the PAINAD scale 
stated that a higher score on the PAINAD scale is asso-
ciated with a lower degree of dependence for basic day- 
to- day activities according to the Barthel Index and with a 
lower use of analgesics.
Reliability
Reliability was assessed through analysis of internal consis-
tency, interobserver variability and intraobserver tempo-
rary stability (test–retest). A second pain assessment was 
performed at 30 days to assess stability over time.
Statistical analysis
The median, mean, SD, maximum and minimum of 
the quantitative variables and the absolute and relative 
frequencies of the categorical variables were calculated to 
describe the general characteristics of the patients.
The Content Validity Index was calculated to evaluate 
the content validity of the PAINAD scale. For this purpose, 
it was necessary to calculate:
 ► The number of agreements, understanding ‘agree-
ment’ as the number of experts who gave the item a 
score of 3 or 4 in the evaluation of relevance.
 ► The level of the validity of the item (Item Content 
Validity Index (I- CVI)), considering scores 
greater than or equal to 0.78 as acceptable43 44 
( I − CVI =
number of raters scoring an item with a 3 or 4
total experts  ).
 ► The probability of random concordance (pc), 

















 ► The modified kappa coefficient. The criteria applied 
was the one defined by Fleiss (1981), who established 
four ratings: excellent (≥0.74), good (0.60–0.73), 




 ► The average of all I- CVI scores. A minimum score of 
0.80 was accepted as adequate validity, while ≥0.90 
represented a high validity.45
Regarding construct validity, the Pearson or Spearman’s 
Rho correlation indexes were calculated according to the 
distribution of the data, seeking the association between 
the Barthel Index score or the number of analgesics per 
day and the PAINAD score.
The statistical method used to check internal consis-
tency was Cronbach’s alpha coefficient, considering alpha 
values above 0.7 as good internal consistency. In addition, 
the confirmatory factor analysis (CFA) was used to assess 
the goodness- of- fit of the factor structure. The intraclass 
correlation coefficient (ICC) was used to assess variability 
between observers and temporary stability.
IBM SPSS Statistics 22.0 (SPSS/IBM), Epidat V.4.1 
(Department of Sanida, Xunta de Galicia, Galicia, Spain) 
and the Lavaan R package software (V.3.5.0) have been 
used for the statistical analysis of the data. The level of 
statistical significance was set at an alpha error below 5% 
for all the statistical tests and a CI of 95%.
Ethical aspects
The principles of the Declaration of Helsinki and the 
Belmont report on ethical precepts for biomedical were 
followed thoroughly. In this sense, the relatives, or legal 
representatives of the candidates for entry into the study 
were informed through a Patient Information Sheet and 
the written informed consents were obtained. Subject 
anonymity and data confidentiality were always guaran-
teed. In addition, the study has the authorisation of all 
participating centres and the permission of the Ethics 
Committee for Research of Andalusia (Acta n° 271, ref. 
3672, approved on 5 December 2017).
Patient and public involvement
The research question for this study was developed based 
on the available scientific literature on the subject. There-




A total of 100 patients with dementia or AD constituted 
the final study sample. Their sociodemographic and clin-
ical characteristics are shown in table 1.
PAINAD validation
Linguistic adaptation and validation
The back- translation of the García- Soler tool38 showed a 
discrepancy rate of 7%, so the process of linguistic vali-
dation of the tool had to be restarted. The last transla-
tion did not exceed 5% discrepancy, which allowed the 
Spanish version to be considered appropriate for its 
application.
Content validity
The overall content validity of the Spanish from Spain 
version of the PAINAD scale (S- CVI) was 0.95, with a 
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minimum I- CVI of 0.875 and a maximum of 1.00. The 
results of the content validity indicators for each of the 
dimensions constituting the PAINAD scale are shown in 
table 2.
Construct validity
The construct validity of the PAINAD scale was evaluated 
assuming that a lower level of pain in this tool was asso-
ciated with a lower degree of dependence for the basic 
activities of daily life according to the Barthel Index and 
a lower use of analgesic drugs. However, the results indi-
cate that according to Pearson’s correlation coefficient 
there is no association between the Barthel Index score 
and the PAINAD score, regardless of observer 1 (p=0.45), 
observer 2 (p=0.66) or observer 3 (p=0.95).
However, regarding the correlation between the 
PAINAD score and the number of analgesics used by 
patients with advanced dementia, the latter was signifi-
cantly lower in those patients with a lower PAINAD score. 
Specifically, according to observer 1, p=0.002 (95% CI: 
0.044 to 0.523), for observer 2, p<0.001 (95% CI: 0.067 




The overall Cronbach’s alpha coefficient value was 0.76. 
However, if we remove the breathing dimension from 
the analysis since it is a constant, the overall value of 
Cronbach’s alpha increases to 0.81. In the same way, the 
overall value of Cronbach’s alpha coefficient was 0.81 in 
the retest, increasing to 0.85 if the breathing dimension 
is removed. Table 3 shows the internal consistency results 
of both the test and retest for each of the three observers, 
both including the breathing dimension of the scale and 
after its removal.
Furthermore, table 4 shows the internal consistency 
results for each item of the PAINAD scale. Breathing was 
not included because its values were a constant.
Finally, the CFA was used to assess the goodness- of- fit 
of the factor structure of five items for median of the 
observations. We obtained a good fit in terms of the 
comparative fit index which was 0.947 (breathing was 
not used).
Inter-observer variability
To evaluate the interobserver agreement of the Spanish 
version of PAINAD scale, the overall ICC value was 0.94 
(95% CI: 0.92 to 0.96). In this regard, the ICC was 0.91 
(95% CI: 0.88 to 0.93) for the negative vocalisation item, 
0.84 (95% CI: 0.79 to 0.89) for the facial expression, 0.78 
(95% CI: 0.70 to 0.83) for the body language and 0.61 
(95% CI: 0.50 to 0.70) for consolability.
Temporary stability
The overall ICC between the pre- test and post- test scores 
was 0.55 (95% CI: 0.32 to 0.70), p<0.001. In this case, the 
ICC value was 0.50 (95% CI: 0.26 to 0.67), p<0.001 for the 
negative vocalisation, 0.63 (95% CI: 0.44 to 0.75), p<0.001 
for facial expression, 0.52 (95% CI: 0.30 to 0.68), p<0.001 
for body language and 0.51 (95% CI: 0.26 to 0.57) for 
consolability.
Table 2 Results of the content validity of the Spanish 
version of the PAINAD scale
I- CVI pc k Rating*
Breathing 0.88 0.031 0.87 Excellent
Negative vocalisation 0.88 0.031 0.87 Excellent
Facial expression 1.00 0.004 1.00 Excellent
Body language 1.00 0.004 1.00 Excellent
Consolability 1.00 0.004 1.00 Excellent
*Evaluation criteria of kappa according to Fleiss.45
I- CVI, Item Content Validity Index; k, modified kappa coefficient 
obtained by designing the relevant proportion of agreements; ; 
PAINAD, Pain Assessment in Advanced Dementia; pc, probability 
of random agreement.
Table 1 Characteristics of the study sample
Variable
Age (years) Mean (SD) 83.80 (7.82)
Min–Max 65–95
Me 83.80
Sex Male 78 (78%)
Female 22 (22%)
Marital status Single 9 (9%)
Married 27 (27%)









Mixed dementia 13 (13%)
GDS GDS 5 13 (13%)
GDS 6 42 (42%)
GDS 7 45 (45%)
Barthel Index 
score
Mean (SD) 18.55 (21.30)
Min–Max 0–80
Me 18.55




Mean (SD) 0.73 (1.09)
Min–Max 0–6
Me 0
.AD, Alzheimer's disease; GDS, Global Deterioration Scale; Max, 
maximum; Me, mean; Min, minimum.
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DISCUSSION
The results of the study show that the Spanish version of 
the PAINAD scale, according to its psychometric proper-
ties and in line with previous studies,39 is a valid observa-
tional tool for assessing pain in people with dementia and 
impaired verbal communication.
The Spanish version of the PAINAD scale, based on the 
results of the present study, shows an excellent content 
validity. In this sense, if we compare the Spanish version 
with the Turkish one, the mean value of the I- CVI in the 
Turkish version was 0.84, and given that the value of the 
Spanish version was 0.95, we can affirm that the Spanish 
version is better.36
Regarding the association between the PAINAD scale 
score and the degree of dependence for basic activi-
ties of daily living measured through the Barthel Index 
(used to evaluate construct validity), the results have not 
shown that those subjects with advanced dementia and 
a lower level of pain also have a lower degree of depen-
dence. However, this could be explained by the degree 
of dependence of the subjects constituting the sample, 
since 93% (n=93) had dependence classified as severe or 
total, according to the Barthel Index. Specifically, 30% 
(n=30) had severe dependence and 63% (n=63) had total 
dependence on basic activities of daily life. In contrast, 
the expected results for lower analgesic use among those 
with advanced dementia who had lower pain levels have 
been verified, according to the PAINAD scale.
The found reliability was similar to the values obtained 
in the validation of other languages, such as the Italian 
version of this tool, with an internal consistency of 
0.7431; the Brazilian version, whose value of the Cron-
bach’s alpha was 0.6535 or the German version, which 
has the best results, since internal consistency reached 
0.85.37
However, the results of the Spanish version of the 
PAINAD scale are even better if we remove the breathing 
dimension (Cronbach’s alpha of 0.81 and 0.85). Some-
thing similar occurs in the García- Soler version, with a 
Cronbach’s alpha value ranging from 0.47 to 0.83 (with 
a mean of 0.70), which was higher if the breathing item 
was removed38; or the Chinese version of the scale, which 
initially ranged from 0.55 (during assisted transfer) to 
0.66 and increased to 0.71 if the breathing dimension was 
removed from the analysis.32
Regarding the degree of agreement among observers, 
the ICC values of this version (0.94) are higher than those 
found by the Chinese version (0.84)32 and the Turkish 
version (0.81).36
Finally, regarding temporary stability, the findings 
of this study have shown a moderate reliability of the 
PAINAD scale in its Spanish version, since the ICC is 0.55. 
This has been lower than other versions, since the ICC of 
the Chinese version ranges from 0.80 to 0.86,32 the ICC 
of the Turkish version is 0.81,36 the ICC of the German 
version is 0.8037 and the ICC of the Italian version is 
0.88.31 This difference could be explained because the 
retest was performed after a shorter time interval31 32 in 
other studies, such as in the German version,37 which 
performed both the test and the retest on the same day. 
However, despite choosing a longer period of time for 
our study, we ensured that no relevant clinical variation 
Table 3 Internal consistency of the scale according to the observer. Cronbach’s alpha values
Cronbach’s alpha 95% CI
Cronbach’s alpha if the breathing 
dimension has been deleted 95% CI
Test
Observer 1 0.803 0.779 to 0.874 0.857 0.815 to 0.894
Observer 2 0.780 0.715 to 0.837 0.831 0.781 to 0.875
Observer 3 0.710 0.624 to 0.785 0.743 0.667 to 0.810
Retest*
Observer 1 0.795 0.732 to 0.849 0.845 0.798 to 0.886
Observer 2 0.825 0.772 to 0.8171 0.880 0.843 to 0.912
Observer 3 0.810 0.752 to 0.860 0.832 0.781 to 0.877
*The sample consisted of 95 patients due to the death of some of the study subjects.
Table 4 Internal consistency results for each item. Cronbach’s alpha values
Corrected total element 
correlation
Cronbach’s alpha if the element 
has been deleted 95% CI
Negative vocalisation 0.83 0.73 0.65 to 0.80
Facial expression 0.70 0.77 0.70 to 0.83
Body language 0.70 0.78 0.72 to 0.84
Consolability 0.71 0.76 0.69 to 0.82
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had occurred during those 30 days that could have inter-
fered with the measurement.
Strengths and limitations
Before the validation step, the PAINAD scale was trans-
lated and backtranslated using a rigorous methodology 
despite the existence of a previous version in Spanish, 
which is a strength of our study. In addition, the PAINAD 
scale was filled in by three researchers who had previ-
ously received training in its use to assess pain in patient 
with advanced dementia and inability to communicate. 
Furthermore, external conditions were controlled as 
much as possible during the data collection process to 
minimise potential interference with the scale validation 
process.
However, there are also some limitations to this study. 
The use of consecutive sampling may have influenced the 
selection of subjects. However, there was no prior list of 
patients meeting the inclusion criteria, or even an esti-
mate of the total number of patients with these charac-
teristics. On the other hand, it should be noted that the 
test–retest is limited by the time elapsed between the two 
observations. However, the pre- existing scientific litera-
ture had used different temporalities to assess this psycho-
metric property (reliability), so the results of the present 
study in this respect are adequate.
Implications for clinical practice and research
The PAINAD scale, according to its psychometric proper-
ties as well as its simplicity, presents itself as a promising 
instrument to combat both underdiagnosis and under-
treatment of pain in patients with dementia and commu-
nication disability. However, it is important to take into 
consideration the need for health professionals who will 
be using the PAINAD scale to have adequate and specific 
training in its use.
Further studies are needed to identify the level of satis-
faction of health professionals with its daily use in the 
care setting; to find out the limitations and difficulties 
of the inclusion of the scale in the care of patients with 
advanced dementia; as well as to determine the impact of 
its use in pain assessment.
CONCLUSIONS
The Spanish adaptation of the PAINAD scale seems 
to be a reliable and valid tool to evaluate pain in older 
people with advanced dementia and unable to commu-
nicate effectively verbally. In this regard, the PAINAD 
has shown an excellent content validity; an adequate 
construct validity for the studied phenomenon according 
to the correlation between the PAINAD score and the use 
of analgesics. In addition, the PAINAD scale has shown 
a high reliability, with an excellent internal consistency 
at the overall level both at the initial visit and at the 
retest, increasing if the breathing dimension is removed; 
a moderate temporary stability and an excellent general 
intraobserver reliability.
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